Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-news-1/latest-analysis-confirms-suboptimal-vitamin-d-levels-in-millions-of-us-children-10517-1/;+health+history;+medical+history.html) was not found.

Search biology news 1 latest analysis confirms suboptimal vitamin d levels in millions of us children 10517 1 ;+health+history;+medical+history html at Google

Search biology news 1 latest analysis confirms suboptimal vitamin d levels in millions of us children 10517 1 ;+health+history;+medical+history html at Yahoo

Search biology news 1 latest analysis confirms suboptimal vitamin d levels in millions of us children 10517 1 ;+health+history;+medical+history html at Msn

Google
 
(Date:12/4/2009)... University of Iowa investigators have shown how activation of ... the electrical activity of heart cells. , ... online Dec. 3 in the journal PLoS Computational ... interest in calmodulin kinase II as a critical regulator ...
(Date:12/3/2009)... ability to learn new information and adapt to changes in ... appears to lie in the minute junctions where nerve cells ... Center researchers. The study is published online this week in ... by Wen-Biao Gan, PhD, associate professor of physiology and neuroscience ...
(Date:12/3/2009)... year, the CTRC-AACR San Antonio Breast Cancer Symposium continues ... world leaders from industry and academia with the goal ... than 8,500 scientists and other professionals will gather at ... from Dec. 9-13, 2009. The symposium is a partnership ...
Breaking Biology News(10 mins):U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Senior Citizens Bureau Creates New Resourceful Divisions 48034 1Senior Citizens Bureau Creates New Resourceful Divisions 48034 2As Biking Popularity Grows so Must the Spotlight on Safety 48031 1As Biking Popularity Grows so Must the Spotlight on Safety 48031 2As Biking Popularity Grows so Must the Spotlight on Safety 48031 3Career Step Partners with Piedmont Community College to Help Students Gain Careers in Growing Healthcare Industry 48027 1Career Step Partners with Piedmont Community College to Help Students Gain Careers in Growing Healthcare Industry 48027 2
(Date:12/7/2009)... Researchers at the University of Chicago have discovered a ... has obstructive sleep apnea (OSA) or habitual snoring by ... the possibility of developing a relatively simple urine test ... alleviate the need for costly and inconvenient sleep studies ... percent of whom actually have OSA," said lead author ...
(Date:12/6/2009)... become a mainstay of multiple myeloma treatment may ... of patients who have received stem cell transplants ... clinical trial results to be presented by ... Society of Hematology,s (ASH) annual meeting on Sunday, ... Center, Room 243-245, 5:45 pm CT). , ...
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 2b 003-A1 study, known as the 003 trial, ... relapsed and refractory multiple myeloma patients. These data ... at the 51st annual meeting of the American ... in this trial is complete (n=269), and full ...
(Date:12/6/2009)... of the community, in cooperation with the Greater VA Healthcare System ... This year,s attendance is expected to soar to more than 5,000 ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members ... in West Los Angeles, will once again create a holiday party. ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
Breaking Medicine News(10 mins):Health News:Urine test for pediatric obstructive sleep apnea possible 2Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3
Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Biology Products:
... EpochXP Workstations provide comprehensive neurological monitoring ... care unit to accurately access your ... over 15 years experience, and a ... EpochXP neurological monitoring systems have a ...
... powerful, multi-modality system capable of performing EP (including ... and train of four testing tests simultaneously. The ... The base weighs only 4.25 lbs. A complete ... desktop PC-based system with a custom cart can ...
... neuromonitoring system especially designed for surgical monitoring ... 16 channels and is equipped with two ... channel can be independently configured as either ... channel. Endeavor amplifiers are based on the ...
... Katena Products, Inc. is the ... dedicated exclusively to ophthalmic surgical ... to over 7,000 customers in ... a global network of distributors, ...
Medicine Products:
(Date:12/4/2009)... Inc. (OTC Bulletin Board: BFRE), a company focused on changing ... from non-food cellulosic wastes, has been ranked number 19 on ... Companies in Bioenergy;" the company,s second consecutive year in the ... the top 20 bioenergy companies for two straight years is ...
(Date:12/3/2009)... 3 ACCESS PHARMACEUTICALS, INC. ... update on its European commercial launch of MuGard, an ... effect of radiation treatment and chemotherapy. MuGard is commercially ... including the UK, Germany, Italy, Norway, Greece and Sweden. ...
(Date:12/3/2009)... 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today ... second quarter of fiscal year 2010 on December 10, 2009 ... and webcast to discuss the results at 11:30 a.m. EST ... financial results for the second quarter ended October 31, 2009 ...
(Date:12/3/2009)... Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at ... spoke at a conference on High-Risk Diabetic,Foot Care ... is China,s leading,stem cell research and regenerative medicine ... organized by the Indian Podiatry Association (IPA), aimed,to ...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, ... President and Chief Financial Officer. In this role, ... administrative functions including finance, accounting, IT, IR, administration and ... Company,s senior management team. ,, "One of my ...
(Date:12/4/2009)... Shore and E. David Crawford presented results for prostate-specific ... end points of biochemical recurrence rate in a Phase ... or monthly leuprolide in prostate cancer patients during the ... received FIRMAGON 240/80 mg/month had a recurrence rate of ...
(Date:12/3/2009)... a subsidiary of Hill-Rom Holdings, Inc. (NYSE: ... Allen Amatech(TM) OEM (Original Equipment Manufacturer) business website ... the Allen Amatech(TM) brand identity and includes an online ... and design specifications for the products. "We hope to ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 1Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 2Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 1Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 2Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 1Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 2Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 3Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 4